This new test ( EndoTest for endometriosis) is based on gene sequencing and use of AI ( Artificial intelligence), a cutting edge technology in this modern era.

• It can accurately detect endometriosis by sequencing microRNA from saliva using Next Generation Sequencing (NGS)
• So far EndoTest has shown a solution with superior performance to all currently available diagnostic tools (laparoscopy, MRI, pelvic ultrasound).
• It has been developed by a French company, and has been validated by one of the largest clinical studies for endometriosis, in collaboration with 6 French centres specialising in endometriosis.
• The benefit of using EndoTest is to quickly confirm or exclude the diagnosis of endometriosis with a high reliability.
• Performance wise, EndoTest is non-invasive and os easy-to-use test, reliably detects endometriosis and removes doubts in the most complex cases (sensitivity of 97%, specificity of 100%, diagnostic accuracy of 98%). Laparoscopy has about 80% diagnostic accuracy

An early diagnosis could result in

• Early treatment of endometriosis
• Single test to diagnose endometriosis
• Optimising fertility care
• Limiting the quality of life deterioration
• Avoids invasive testing and costs related to laparoscopy and complications associated with it.

Reference:

#pelvicpain #endomerriosis #adenomyosis #qol #diagnosis